# Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease

> **NCT06809413** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Beijing Chest Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Fluoroquinolone
- Mycobacterium

## Interventions

- **DRUG:** Sitafloxacin

## Key facts

- **NCT ID:** NCT06809413
- **Lead sponsor:** Beijing Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-01-28
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06809413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06809413, "Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06809413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*